Clinical Trial: Evaluate the Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Antagonists in Patients With Dry Eye Disease and Asthenopia
Study Status: Completed
Recruit Status: RECRUITING
Condition: Dry Eye
Study Type: OBSERVATIONAL
Official Title: An Investigator-Initiated Phase 2a, Open-Label Study to Evaluate the Safety and Efficacy of CGRP Antagonists in Patients With Dry Eye Disease and Asthenopia
Brief Summary:
Safety and Efficacy of Medications for Migraine in Patients with Dry Eye Disease or Asthenopia
Read more